Found 6 matching trials
Phase 2a, AMP Challenge, Dose Escalation Study to Assess the Dose Response for Topical Efficacy and Systemic Activity in Asthmatic Subjects
PHASE2This is a randomized, placebo-controlled, 2-period crossover, escalating re...
Location
GSK Investigational Site
Dose Response AMP Challenge Study With Beclometasone Dipropionate (BDP)/Formoterol Pressurised Metered Dose Inhaler (pMDI)
PHASE2The aim of this exploratory investigation is to evaluate if the Forced Expi...
Location
Respiratory Clinical Trials - Heart Lung Centre - Queen Anne Street Medical Centre
ATP/AMP Challenge in Healthy Non-smokers, Smokers, Patients With Asthma, and Patients With Chronic Obstructive Pulmonary Disease (COPD)
NAIn this randomised, cross-over, controlled study, a total of 84 subjects wi...
Location
Section of Airway Disease, Asthma Lab, Imperial College London, Royal Brompton Hospital
AMP-BPT and His-BPT for Assessment of Asthma
NAAdenosine monophosphate (AMP) may reflect airway inflammation and hyperresp...
Location
Multiple Locations
Study on the Effects of an AMP Challenge on Asthmatic Patients Following Treatment With Fluticasone Propionate
PHASE2Inhaling AMP causes an inflammatory response in the lung. This study will i...
Location
GSK Investigational Site
Determining the Optimal Adenosine Provocation Test
NAAsthma is a frequently occurring inflammatory lung disease that affects the...
Location
University Medical Center Groningen